Bio-Path Holdings, Inc. (BPTH)
0.0005
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
Bio-Path Holdings Enterprise Value : 0.5441M for Nov. 3, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 0.5441M |
| November 02, 2026 | 0.5341M |
| October 30, 2026 | 0.5341M |
| October 29, 2026 | 0.5341M |
| October 28, 2026 | 0.5341M |
| October 27, 2026 | 0.5341M |
| October 26, 2026 | 0.5341M |
| October 23, 2026 | 0.5341M |
| October 22, 2026 | 0.5341M |
| October 21, 2026 | 0.5341M |
| October 20, 2026 | 0.5341M |
| October 19, 2026 | 0.5341M |
| October 16, 2026 | 0.5341M |
| October 15, 2026 | 0.5341M |
| October 14, 2026 | 0.5492M |
| October 13, 2026 | 0.5341M |
| October 12, 2026 | 0.5341M |
| October 09, 2026 | 0.5291M |
| October 08, 2026 | 0.5291M |
| October 07, 2026 | 0.5441M |
| October 06, 2026 | 0.5441M |
| October 05, 2026 | 0.5441M |
| October 02, 2026 | 0.5341M |
| October 01, 2026 | 0.524M |
| September 30, 2026 | 0.524M |
| Date | Value |
|---|---|
| September 29, 2026 | 0.524M |
| September 28, 2026 | 0.5441M |
| September 25, 2026 | 0.5441M |
| September 24, 2026 | 0.5291M |
| September 23, 2026 | 0.5441M |
| September 22, 2026 | 0.5441M |
| September 21, 2026 | 0.5291M |
| September 18, 2026 | 0.5291M |
| September 17, 2026 | 0.524M |
| September 16, 2026 | 0.524M |
| September 15, 2026 | 0.524M |
| September 14, 2026 | 0.524M |
| September 11, 2026 | 0.524M |
| September 10, 2026 | 0.5341M |
| September 09, 2026 | 1.812M |
| September 08, 2026 | 1.812M |
| September 04, 2026 | 1.812M |
| September 03, 2026 | 1.274M |
| September 02, 2026 | 1.525M |
| September 01, 2026 | 1.701M |
| August 31, 2026 | 1.827M |
| August 28, 2026 | 1.827M |
| August 27, 2026 | 2.028M |
| August 26, 2026 | 2.028M |
| August 25, 2026 | 2.128M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vaxxinity, Inc. | -- |
| Myrexis, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 8.177B |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | 44.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.636M |
| Total Expenses (Quarterly) | 2.636M |
| EPS Diluted (Quarterly) | -0.0875 |
| Earnings Yield | -51.56K% |
| Normalized Earnings Yield | -36160.00 |